Insider Transactions in Q2 2024 at Ardelyx, Inc. (ARDX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
2,310
-0.18%
|
$13,860
$6.59 P/Share
|
|
Jun 21
2024
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
38,000
-10.49%
|
$190,000
$5.96 P/Share
|
|
Jun 14
2024
|
Richard J Rodgers Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,204
+4.65%
|
-
|
|
Jun 14
2024
|
William C Bertrand Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,023
+4.58%
|
-
|
|
Jun 14
2024
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,322
+1.41%
|
-
|
|
Jun 13
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
35,000
-2.68%
|
$210,000
$6.65 P/Share
|
|
Jun 13
2024
|
Michael Raab President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+2.61%
|
$0
$0.99 P/Share
|
|
Jun 05
2024
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
145,000
-16.66%
|
$1,015,000
$7.12 P/Share
|
|
Jun 05
2024
|
Laura A Williams Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+17.63%
|
$200,000
$2.75 P/Share
|
|
Jun 03
2024
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
17,872
-10.13%
|
$125,104
$7.0 P/Share
|
|
May 29
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.59%
|
$45,000
$6.72 P/Share
|
|
May 21
2024
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,703
-1.47%
|
$46,921
$7.81 P/Share
|
|
May 21
2024
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
2,198
-1.23%
|
$15,386
$7.81 P/Share
|
|
May 21
2024
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,855
-1.27%
|
$33,985
$7.81 P/Share
|
|
May 21
2024
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,794
-1.29%
|
$33,558
$7.81 P/Share
|
|
May 21
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
31,484
-2.4%
|
$220,388
$7.81 P/Share
|
|
May 21
2024
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,167
-1.69%
|
$36,169
$7.81 P/Share
|
|
May 21
2024
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
6,927
-3.36%
|
$48,489
$7.81 P/Share
|
|
May 21
2024
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
4,855
-1.32%
|
$33,985
$7.81 P/Share
|
|
May 21
2024
|
Robert Ora Felsch Officer |
SELL
Open market or private sale
|
Direct |
3,485
-3.53%
|
$24,395
$7.81 P/Share
|
|
May 14
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.23%
|
$21,000
$7.99 P/Share
|
|
May 06
2024
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
284,170
-32.54%
|
$2,273,360
$8.88 P/Share
|
|
May 06
2024
|
Elizabeth A Grammer Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
219,937
+20.46%
|
$219,937
$1.87 P/Share
|
|
May 06
2024
|
Robert Ora Felsch Officer |
SELL
Open market or private sale
|
Direct |
207,988
-43.39%
|
$1,663,904
$8.81 P/Share
|
|
May 06
2024
|
Robert Ora Felsch Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
119,101
+17.34%
|
$119,101
$1.8 P/Share
|
|
May 03
2024
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
45,000
-14.38%
|
$405,000
$9.0 P/Share
|
|
May 03
2024
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
39,949
-9.74%
|
$319,592
$8.35 P/Share
|
|
May 03
2024
|
Laura A Williams Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+6.82%
|
$0
$0.99 P/Share
|
|
Apr 29
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-2.24%
|
$180,000
$6.4 P/Share
|
|
Apr 29
2024
|
Michael Raab President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+2.19%
|
$0
$0.99 P/Share
|
|
Apr 15
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.57%
|
$52,500
$7.06 P/Share
|
|
Apr 01
2024
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
1,518
-0.12%
|
$10,626
$7.31 P/Share
|